NASDAQ:HCTI • US42227W4050
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HEALTHCARE TRIANGLE INC (HCTI).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-09-28 | EF Hutton | Maintains | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 45.89M 30.11% | 33.203M -27.65% | 11.696M -64.77% | 17.194M 47.01% | 24.911M 44.88% | 29.894M 20.00% | 35.872M 20.00% | |
| EBITDA YoY % growth | -7.05M -78.93% | -4.419M 37.32% | -3.862M 12.60% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -10.42M -94.40% | -5.985M 42.56% | -4.751M 20.62% | -6.89M -45.02% | -3.706M 46.22% | -1.426M 61.52% | 1.672M 217.25% | |
| Operating Margin | -22.71% | -18.03% | -40.62% | -40.07% | -14.88% | -4.77% | 4.66% | |
| EPS YoY % growth | N/A | N/A 40.00% | N/A 25.00% | -186.66 -203,233.33% | -54.06 71.04% | -22.44 58.49% | 0.20 100.91% |
All data in USD
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -12.24 |
| Revenue Q2Q % growth | 6.228M 184.38% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -1.435M -188.18% |
All data in USD
7 analysts have analysed HCTI and the average price target is 306 USD. This implies a price increase of 11371.42% is expected in the next year compared to the current price of 2.6675.
The consensus EPS estimate for the next earnings of HEALTHCARE TRIANGLE INC (HCTI) is -12.24 USD and the consensus revenue estimate is 6.23M USD.
The number of analysts covering HEALTHCARE TRIANGLE INC (HCTI) is 7.